Ultrasound Market to Reach $16.0 Billion by 2035 at 5.3% CAGR | GE HealthCare, Philips, Fujifilm Lead Global Competition

The global ultrasound market, valued at USD 8.9 billion in 2024, will grow to USD 9.6 billion in 2025 and reach USD 16.0 billion by 2035, advancing at a CAGR of 5.3% over the forecast period. Rising chronic disease burden, expanding geriatric populations, and accelerating adoption of AI-assisted and point-of-care imaging systems are collectively pushing demand well beyond historical growth rates across every major region.

To explore the complete findings, request a free sample of the report at https://www.rootsanalysis.com/reports/ultrasound-market/request-sample.html

Market Overview
Ultrasound imaging, or ultrasonography, uses high-frequency sound waves to produce real-time images of internal organs and tissues without exposing patients to ionizing radiation. Its applications span obstetrics, cardiology, general radiology, urology, vascular imaging, and an expanding range of therapeutic uses, making it one of the most versatile and widely deployed modalities in modern medicine. Hospitals, outpatient clinics, diagnostic centers, and emergency departments rely on ultrasound as a front-line, cost-effective diagnostic tool precisely because it delivers rapid answers without the risks or costs associated with CT or MRI.

The market sits at an inflection point. Conventional cart-based systems still dominate high-volume hospital imaging departments, but a wave of miniaturized, AI-enabled handheld devices is broadening the user base to emergency physicians, rural practitioners, and general practitioners who need bedside diagnostics without specialized training. Recent investments reinforce the trajectory: in April 2025, SecondWave secured USD 7 million in Series A funding to develop ultrasound devices for inflammatory disorders, while Flosonics Medical raised USD 5.2 million to accelerate adoption of its FloPatch wireless wearable ultrasound technology. At the partnership level, NVIDIA and GE Healthcare announced a collaboration in March 2025 to integrate physical AI into autonomous ultrasound applications, signaling that the sector's next growth phase will be software-defined.

Humanitarian and institutional investment is expanding access in under-served regions as well. In January 2025, Philips and the Bill and Melinda Gates Foundation announced deployment of the Lumify ultrasound system through Rwanda's Imbuto Foundation, targeting maternal health outcomes in remote communities. These initiatives are both socially meaningful and commercially significant, as they seed demand in markets that will require equipment upgrades over the following decade.

Key Growth Drivers
Rising prevalence of chronic and cardiovascular diseases. Cardiovascular disorders, cancer, and metabolic conditions are increasing globally, particularly in aging populations. Ultrasound offers a radiation-free, repeatable method for monitoring these conditions over time, driving consistent, recurring equipment demand at hospitals and outpatient facilities alike.

Expansion of handheld and point-of-care devices. Compact ultrasound devices that connect to smartphones and tablets are making diagnostic imaging accessible outside radiology departments. Emergency physicians, intensivists, and rural healthcare providers are adopting them for bedside use, broadening the total addressable market well beyond traditional imaging specialists.
Integration of artificial intelligence. AI algorithms now improve image resolution, suppress artifacts, provide real-time guidance during scans, and flag findings for clinical review. These capabilities reduce the skill threshold for performing and interpreting ultrasound, making adoption viable in lower-resource settings and accelerating exam throughput in high-volume facilities.

Growth of therapeutic ultrasound applications. High-Intensity Focused Ultrasound (HIFU) and related technologies are gaining clinical acceptance as non-surgical alternatives for cancer treatment, physiotherapy, and women's health procedures. Hologic's USD 350 million acquisition of Gynesonics in January 2025, targeting uterine fibroid treatment via intrauterine ultrasound, illustrates how therapeutic ultrasound is opening new commercial segments for device makers.

Increased healthcare expenditure in emerging markets. Government investment in public healthcare infrastructure across Asia-Pacific, Latin America, and the Middle East is bringing ultrasound systems to hospitals and diagnostic centers that previously lacked imaging capacity. Maternal health programs and rural outreach initiatives are generating sustained procurement demand in these regions.

Market Segmentation
Diagnostic ultrasound systems currently hold approximately 80% of total market revenue, reflecting their deep integration across obstetrics, cardiology, emergency care, and routine imaging. Therapeutic ultrasound systems represent the smaller share today, but they are the faster-growing segment, attracting investment from specialty clinics and cancer treatment centers drawn to the clinical and commercial appeal of non-invasive procedural alternatives. By device portability, trolley and cart-based systems account for roughly 90% of the market, favored for their superior image quality and multi-transducer versatility in high-volume departments. Handheld and point-of-care devices will grow at the highest CAGR through 2035, driven by expanding use in emergency departments, intensive care units, and remote settings.

The colored display segment holds approximately 80% of the display-type market, preferred for its Doppler color-flow imaging capabilities across cardiology, obstetrics, and vascular work. Among technologies, 2D ultrasound accounts for 35% of the market, maintaining dominance through its clinical ubiquity and low operating cost, while 3D/4D systems will post the highest CAGR as women's health centers and specialty clinics invest in advanced fetal and structural imaging. By application, radiology and general imaging leads all segments due to the sheer breadth of conditions it covers. Cardiology will register the highest application-level growth rate, propelled by the global cardiovascular disease burden. Hospitals are the largest end-user segment; independent diagnostic centers are the fastest-growing, recording a projected CAGR of 7.2% as outpatient care preferences shift spending away from hospital-based services.

To request quote of this report, please visit:
https://www.rootsanalysis.com/reports/ultrasound-market/request-quote.html

Regional Insights
North America currently captures approximately 50% of global ultrasound market revenue and will retain its leading position through 2035. The region's strength comes from well-developed hospital networks, strong reimbursement frameworks for ultrasound-based diagnostics, and the presence of leading manufacturers who drive continuous product innovation and rapid technology refresh cycles. The US generates the largest portion of regional demand, supported by high prevalence of chronic disease and an aging population that requires frequent diagnostic monitoring.

Asia-Pacific is on track to register the highest CAGR in the global ultrasound market at 6.9% through 2035, making it the most compelling growth opportunity for manufacturers and investors. China, India, and neighboring markets are directing significant government expenditure toward public healthcare infrastructure, maternal health programs, and rural diagnostic outreach, all of which translate directly into ultrasound procurement. The region's large and young patient population, combined with a rapidly expanding middle class that is gaining access to private diagnostics, creates a structural demand base that will grow for decades. Europe maintains a strong position based on sophisticated healthcare systems and consistent technology adoption, while Latin America and the Middle East and North Africa are earlier-stage markets where healthcare investment is beginning to accelerate demand.

Competitive Landscape
The ultrasound market includes more than 100 active manufacturers, with GE HealthCare holding the leading position globally, a result of a disciplined acquisition strategy spanning more than two decades. Key transactions include the purchases of Diasonics Vingmed in 1998, Kretztechnik in 2001, and BK Medical in 2021 for USD 1.45 billion, the last extending GE's reach into surgical and therapeutic ultrasound. Philips holds the second-largest share, built partly through its acquisitions of ATL Ultrasound and HP Medical in the early 2000s and more recently augmented by the purchase of DiA Imaging Analysis in 2023 for AI-powered image analysis. Fujifilm ranks third, having acquired Sonosite in 2012 and Hitachi Diagnostic Imaging in 2021. Other notable players include Siemens Healthineers, Canon Medical Systems, Samsung Healthcare, Shenzhen Mindray Bio-Medical Electronics, Hologic, Esaote, Clarius, and SonoScape, among many others.

The competitive dynamic is consolidating at the top, where large incumbents use acquisitions to absorb AI software developers and specialty ultrasound makers. At the same time, well-funded startups such as Butterfly Network and Clarius are challenging the established order with software-defined handheld platforms. The primary competitive battlegrounds are AI integration, workflow automation, and geographic expansion into high-growth emerging markets.

Browse Full Report Description + Research Methodology + Table of Content + Infographics here:
https://www.rootsanalysis.com/reports/ultrasound-market.html

Contact Details
Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com
Website: https://www.rootsanalysis.com

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

This release was published on openPR.